Details

Autor(en) / Beteiligte

• Crane, Heidi M.
• Nance, Robin M.
• Whitney, Bridget M.
• Ruderman, Stephanie
• Tsui, Judith I.
• Chander, Geetanjali
• McCaul, Mary E.
• Lau, Bryan
• Mayer, Kenneth H.
• Batey, D. Scott
• Safren, Steven A.
• Moore, Richard D.
• Eron, Joseph J.
• Napravnik, Sonia
• Mathews, W. Chris
• Fredericksen, Rob J.
• Hahn, Andrew W.
• Mugavero, Michael J.
• Lober, William B.
• Saag, Michael S.
• Kitahata, Mari M.
• Delaney, Joseph A. C.

Titel

Drug and alcohol use among people living with HIV in care in the United States by geographic region

Ist Teil von

• AIDS care, 2021-12, Vol.33 (12), p.1569-1576

Ort / Verlag

England: Taylor & Francis

Erscheinungsjahr

2021

Quelle

Psychology & Behavioral Sciences Collection

Beschreibungen/Notizen

• Substance use in the U.S. varies by geographic region. Opioid prescribing practices and marijuana, heroin, and methamphetamine availability are evolving differently across regions. We examined self-reported substance use among people living with HIV (PLWH) in care at seven sites from 2017-2019 to understand current regional substance use patterns. We calculated the percentage and standardized percentage of PLWH reporting current drug use and at-risk and binge alcohol use by U.S. Census Bureau geographic region and examined associations in adjusted logistic regression analyses. Among 7,686 PLWH, marijuana use was the most prevalent drug (30%), followed by methamphetamine/crystal (8%), cocaine/crack (7%), and illicit opioids (3%). One-third reported binge alcohol use (32%). Differences in percent of current use by region were seen for marijuana (24-41%) and methamphetamine/crystal (2-15%), with more use in the West and Northeast, and binge alcohol use (26-40%). In adjusted analyses, PLWH in the Midwest were significantly less likely to use methamphetamine/crystal (aOR: 0.13;0.06-0.25) or illicit opioids (aOR:0.16;0.05-0.53), and PLWH in the Northeast were more likely to use cocaine/crack (aOR:1.59;1.16-2.17), compared to PLWH in the West. Understanding differences in substance use patterns in the current era, as policies continue to evolve, will enable more targeted interventions in clinical settings among PLWH.